Bli medlem
Bli medlem

Du är här

2016-05-12

RaySearch Laboratories: RaySearch Laboratories AB (publ) Interim Report January 1 - March 31, 2016

"Revenues from RayStation® increased with 29 percent to SEK 80.8 M
(62.8) and prospects are favorable for increased growth for the rest
of the year. The development of RayCare® is progressing according to
plan and we are planning a public demonstration of the system at the
2016 ASTRO Annual Meeting in Boston at the end of September," says
Johan Löf, President and CEO of RaySearch.

THREE MONTHS (JANUARY-MARCH 2016)

· Net sales SEK 95.4 M (87.7), of which RayStation SEK 80.8 M (62.7)
· Profit after tax SEK 17.8 M (25.0), and earnings per share SEK
0.52 (0.73)

· Operating profit SEK 23.4 M (33.1)
· Cash flow negative SEK 5.2 M (pos: 7.8)
· Order intake excluding service agreements SEK 81.9 M (86.3), of
which RayStation SEK 72.6 M (69.1)

· Order backlog for RayStation was SEK 47.1 M (34.3) at the end of
the period

SIGNIFICANT EVENTS DURING THE FIRST QUARTER

· RaySearch released RayStation 5 with support for carbon ion
treatment planning, as well as tools and features that represent a
totally new approach to treatment planning.

· RaySearch signed a long-term collaboration agreement with the
University of California, San Francisco (UCSF) regarding RayCare.

· On January 4, 2016, the Class B RaySearch share (RAY B) was
transferred from the Small to the Mid Cap segment of Nasdaq
Stockholm.

· In March 2016, 750 Class A shares were converted to Class B shares
at the request of a shareholder.

NO SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIOD

ABOUT RAYSEARCH

RaySearch Laboratories AB (publ) is a medical technology company that
develops advanced software solutions for improved radiation therapy
of cancer. RaySearch markets the RayStation treatment planning system
to clinics all over the world. In addition, RaySearch's products are
distributed through licensing agreements with leading medical
technology companies. RaySearch's software is used by over 2,600
clinics in more than 65 countries. RaySearch was founded in 2000 as a
spin-off from Karolinska Institute in Stockholm, and the company is
listed in the Mid Cap segment on Nasdaq Stockholm.

More information about RaySearch is available at
www.raysearchlabs.com.

FOR FURTHER INFORMATION, PLEASE CONTACT:
Johan Löf, President and CEO
Tel: +46 8 510 530 00
johan.lof@raysearchlabs.com

-----------------------------------------------------------
http://news.cision.com/raysearch-laboratories/r/raysearch-laboratories-a...
http://mb.cision.com/Main/1102/2007559/514698.pdf

Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.